TABLE 2.
Susceptibility to ciprofloxacin | Amino acid change at position:
|
No. of isolates | Reference(s) and/or source | |
---|---|---|---|---|
83 | 87 | |||
Resistant | 9 | 2, 18; this study | ||
Tyr | 15 | 1, 8, 11, 14, 20, 24 | ||
Phe | 10 | 1, 2, 24 | ||
Ile | 7 | 1, 2, 20; this study | ||
Phe | Asn | 17 | 1, 2, 4, 5, 6, 11 | |
Leu | Asn | 13 | 20; this study | |
Tyr | Asn | 10 | 20, 24 | |
Phe | Tyr | 4 | 1, 11 | |
Phe | Ala | 3 | 4, 5, 6 | |
Phe | Gly | 3 | 4, 5, 24 | |
Tyr | Tyr | 2 | 1, 2 | |
Ile | Asn | 1 | 20 | |
Intermediate resistant | 1 | 18 | ||
Tyr | 14 | 1, 4, 5, 8, 20 | ||
Phe | 5 | 1, 4, 5 | ||
Ile | 1 | This study | ||
Gly | 3 | 4, 5; this study | ||
Phe | Gly | 1 | 4, 5 | |
Susceptible | 37 | 4, 5,1, 4, 5, 11, 14, 18, 25; this study | ||
Tyr | 17 | 4, 5,4, 5, 8, 11, 20; this study | ||
Phe | 7 | 4, 5,4, 5, 11, 18, 24 | ||
Leu | 1 | This study | ||
Ile | 1 | This study | ||
Thr | 1 | This study | ||
Gly | 1 | 4, 5 | ||
Asn | 1 | This study | ||
Total | 185 |